CKS2 and chronic myelogenous leukemia, BCR-ABL1 positive: Altogether, these analyses revealed a dysregulation of CKS expression in MLLr leukaemia, but also in BCR-ABL positive CML [47], consistent with putative roles for CKS1B and CKS2 in leukaemogenesis.